154 related articles for article (PubMed ID: 6967756)
1. Inhibition by selected anticancer agents of the development of primary cell-mediated immunity against allogeneic tumor cells in culture.
Orsini F; Eppolito C; Ehrke MJ; Mihich E
Cancer Treat Rep; 1980; 64(2-3):211-8. PubMed ID: 6967756
[No Abstract] [Full Text] [Related]
2. Reversal by peritoneal adherent cells of tumor cell suppression of T cell-mediated immunity.
Ting CC; Rodrigues D
J Immunol; 1979 Aug; 123(2):801-7. PubMed ID: 156764
[No Abstract] [Full Text] [Related]
3. Increased primary cell-mediated immunity in culture subsequent to adriamycin or daunorubicin treatment of spleen donor mice.
Orsini F; Pavelic Z; Mihich E
Cancer Res; 1977 Jun; 37(6):1719-26. PubMed ID: 66985
[TBL] [Abstract][Full Text] [Related]
4. Effect of polyethylene glycol 6000 on the generation of antitumor cytotoxicity in MOPC-315 tumor bearer spleen cells cultured in the presence or absence of inactivated stimulator tumor cells.
Przepiorka D; Mokyr MB; Dray S
Cancer Res; 1980 Dec; 40(12):4565-70. PubMed ID: 7438090
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the cytotoxic response against allogeneic tumor cells in culture by adriamycin.
Tomazic V; Ehrke MJ; Mihich E
Cancer Res; 1980 Aug; 40(8 Pt 1):2748-55. PubMed ID: 6248213
[No Abstract] [Full Text] [Related]
6. Sensitivity of cloned high- and low-metastatic murine Lewis lung tumor cells to lysis by cytotoxic autoreactive cells.
Olsson L; Kiger N; Kronstrom H
Cancer Res; 1981 Nov; 41(11 Pt 1):4706-9. PubMed ID: 6975655
[TBL] [Abstract][Full Text] [Related]
7. Analysis of the mechanism of allograft rejection and cell-mediated immunity. I. Accelerated rejection of tumour allografts without augmented cytotoxicity in the spleen cells.
Nanishi F; Nomoto K; Taniguchi K; Kubo C
Immunology; 1980 May; 40(1):67-76. PubMed ID: 7419243
[TBL] [Abstract][Full Text] [Related]
8. The preclinical screening laboratory: evaluation of immunomodulatory and therapeutic properties of biological response modifiers.
Talmadge JE; Herberman RB
Cancer Treat Rep; 1986 Jan; 70(1):171-82. PubMed ID: 3510733
[No Abstract] [Full Text] [Related]
9. Mechanisms of specific and non-specific tumour immunity after azathioprine treatment of mice.
Purves EC
Clin Exp Immunol; 1975 Nov; 22(2):348-58. PubMed ID: 813934
[TBL] [Abstract][Full Text] [Related]
10. Levamisole augments the cytotoxic T-cell response depending on the dose of drugs and antigen administered.
Faanes RB; Dillon P; Choi YS
Clin Exp Immunol; 1977 Mar; 27(3):502-6. PubMed ID: 405166
[TBL] [Abstract][Full Text] [Related]
11. Comparative study of in vitro and in vivo drug effects on cell-mediated cytotoxicity.
Borel JF
Immunology; 1976 Oct; 31(4):631-41. PubMed ID: 824198
[TBL] [Abstract][Full Text] [Related]
12. Differences in kinetic parameters of lysis by syngeneic and allogeneic T lymphocytes immune to the same tumor.
Huber SA; Lucas ZJ
J Immunol; 1978 Dec; 121(6):2270-7. PubMed ID: 309897
[No Abstract] [Full Text] [Related]
13. Comparative analysis of the immunosuppressive properties of two antiviral, iodinated thymidine analogs, 5-iodo-2'-deoxyuridine and 5-iodo-5'-amino-2',5'-dideoxyuridine.
Kan-Mitchell J; Mitchell MS; Lin TS; Prusoff WH
Cancer Res; 1980 Oct; 40(10):3491-4. PubMed ID: 6969112
[TBL] [Abstract][Full Text] [Related]
14. A possible mechanism of tumor regression in cisplatin-treated mice.
Sarna S; Sodhi A; Bhola RK
Pol J Pharmacol Pharm; 1989; 41(1):69-76. PubMed ID: 2587438
[TBL] [Abstract][Full Text] [Related]
15. Effect of carrageenan on the induction of cell-mediated cytotoxic responses in vivo.
Sakemi T; Kuroiwa A; Nomoto K
Immunology; 1980 Oct; 41(2):297-302. PubMed ID: 6969217
[TBL] [Abstract][Full Text] [Related]
16. Modulation of cell-mediated alloimmunity by BCG. I. Antagonism and potentiation of immunosuppression caused by cytarabine.
Murahata RI; Mitchell MS
J Natl Cancer Inst; 1982 Sep; 69(3):607-12. PubMed ID: 6981020
[TBL] [Abstract][Full Text] [Related]
17. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
Wright SC; Bonavida B
J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
[No Abstract] [Full Text] [Related]
18. Effect of anticancer agents on the susceptibility of tumor cells to immune cytolysis.
Nakao S; Fujii G
Jpn J Exp Med; 1980 Dec; 50(6):435-43. PubMed ID: 7277785
[TBL] [Abstract][Full Text] [Related]
19. [Methodological problems of screening immunotropic agents].
Uteshev BS
Farmakol Toksikol; 1984; 47(3):5-13. PubMed ID: 6610565
[TBL] [Abstract][Full Text] [Related]
20. Native anti-tumor responses elicited by immunization with a low dose of unmodified live tumor cells.
Wu S; Wang SQ; Zhang J; Tan XY; Liu JN
Int J Oncol; 2006 Mar; 28(3):731-6. PubMed ID: 16465379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
